Concomitant medication among persistent opioid users with chronic non‐malignant pain
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Recent guidelines for opioid treatment of chronic non‐malignant pain discourage co‐medication with benzodiazepines and benzodiazepine‐related hypnotics, whereas co‐medication with non‐opioid analgesics and co‐analgesics may offer a beneficial opioid sparing effect, and is recommended. The aim of this study was to describe 1‐year periodic prevalence of co‐medication with benzodiazepines, benzodiazepine‐related hypnotics, non‐opioid analgesics, co‐analgesics and antidepressants in persistent opioid users with chronic non‐malignant pain. Methods: The study is based on data from the Norwegian Prescription Database, covering all drugs dispensed to outpatients in 2008. Concomitant medication levels were compared between users in two definitions of persistent opioid use, all Norwegian adults dispensed opioids in 2008 and the Norwegian background population. Results: Of the Norwegian adult population studied, 1.2% met the criteria of persistent opioid use based on prescription pattern and prescription level. Sixty per cent of persistent opioid users were dispensed a benzodiazepine or benzodiazepine‐related hypnotic in amounts indicating regular use, with 15% dispensed a high amount of both classes. Sixty‐two percent of persistent opioid users were dispensed one or more non‐opioid analgesics, 47% an antidepressant and 33% were dispensed an antiepileptic drug. Conclusion: Approximately 60% of persistent opioid users also receive benzodiazepines or benzodiazepine‐related hypnotics in amounts indicating regular use. This is in conflict with recent guidelines for the treatment of chronic non‐malignant pain and may indicate that these users are at an increased risk of developing problematic opioid use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Depression and Pain Comorbidity: A Literature Review
Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.20.2433 · Cited by 3,463
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Lin, E. H. B., Katon, W., Von Korff, M., Tang, L., Williams, Jr., Kroenke, K., Hunkeler, E., Harpole, L., Hegel, M., Arean, P., et al. (2003) · JAMA · doi:10.1001/jama.290.18.2428 · Cited by 590 · cited 3×
“The distinction between clinically warranted and unwarranted use of these drugs is not possible without clinical data, but it is important to recognise secondary treatment goals besides pain control, such as improving sleep, mood and quality of life, and a combined assessment and treatment is considered necessary for…”
Background
Cited by
Breivik, H., Eisenberg, E., & O’Brien, T. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1229 · Cited by 643
“Of course, the impact of guidelines is dependent on their implementation and levels of adherence among practitioners, and improving this is an important aim [66-69].”
Brandt, J., & Leong, C. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0207-7 · Cited by 356
Trends in the Concomitant Prescribing of Opioids and Benzodiazepines, 2002−2014
Hwang, C. S., Kang, E. M., Kornegay, C. J., Staffa, J. A., Jones, C. M., & McAninch, J. K. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.02.014 · Cited by 190
Metadata
- Authors
- MELLBYE, A., SVENDSEN, K., BORCHGREVINK, P. C., SKURTVEIT, S., & FREDHEIM, O. M. S.
- Venue
- Acta Anaesthesiologica Scandinavica
- Publisher
- Wiley
- Published
- 2012-09-04
- Volume
- 56
- Issue
- 10
- Pages
- 1267-1276
- ISSN
- 0001-5172 (ISSN-L)
- 1399-6576
- OpenAlex
- W1948003901
- Cited by
- 42
- References
- 3
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.